Showing results (901-910 of 2,573) with videos related to

Sort By:
Pageof 258
BMC Endocrine Disorders|January 8, 2021
Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2Elske Quak, Audrey Lasne Cardon, Renaud Ciappuccini, et al.
BMC Endocrine Disorders|January 12, 2021
Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case reportKen Takao, Ayaka Tani, Tetsuya Suwa, et al.
BMC Endocrine Disorders|June 1, 2021
Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomasFang Sun, Yangning Hong, Hexuan Zhang, et al.
BMC Endocrine Disorders|March 11, 2020
Statin prescription among patients with type 2 diabetes in Botswana: findings and implicationsJulius Chacha Mwita, Brian Godman, Tonya M Esterhuizen
BMC Endocrine Disorders|June 17, 2021
DPARD: rationale, design and initial results from the Dutch national diabetes registryJessica C G Bak, Dick Mul, Erik H Serné, et al.
BMC Endocrine Disorders|December 15, 2020
Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year periodXiao-Yan Wu, Dun-Min She, Fang Wang, et al.
BMC Endocrine Disorders|December 11, 2020
Socio-demographic and clinical characteristics of diabetes mellitus in rural Rwanda: time to contextualize the interventions? A cross-sectional studyCharlotte M Bavuma, Sanctus Musafiri, Pierre-Claver Rutayisire, et al.
BMC Endocrine Disorders|December 10, 2022
Clinical characteristics of patients with unexplainable hypothalamic disorder diagnosed by the corticotropin-releasing hormone challenge test: a retrospective studyYuji Hataya, Marie Okubo, Takuro Hakata, et al.
BMC Endocrine Disorders|June 10, 2014
A diagnostic approach for defining idiopathic remitting diabetes: a retrospective cohort studyTarig Babiker, Ali J Chakera, Maggie Shepherd, et al.
BMC Endocrine Disorders|April 17, 2015
The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controlsHassan Kahal, Ahmed Aburima, Tamas Ungvari, et al.
Pageof 258